Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.


Search Results to Michael R Narkewicz

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Narkewicz, Michael

keywords Hepatitis C, Chronic
overview My research is focused on 2 major areas: 1. Cystic Fibrosis Liver Disease. I focus on clinical / translational research focused on identifying the underlying mechanisms of liver disease in CF, developing tests to identify liver disease in CF and to predict the subsequent development of advanced liver disease in CF using radiology, biochemistry and clinical predictors. 2. Clinical trials of antiviral therapy for chronic hepatitis B and C in children and adolescents.

One or more keywords matched the following items that are connected to Narkewicz, Michael

Item TypeName
Academic Article Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C.
Academic Article The "C" of viral hepatitis in children.
Academic Article NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents.
Academic Article Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.
Academic Article Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment.
Academic Article Neonatally acquired hepatitis C--not so risky?
Academic Article Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger.
Academic Article Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C.
Academic Article Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B.
Academic Article Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Academic Article Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.
Academic Article The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
Academic Article Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options.
Academic Article Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.
Academic Article Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.
Concept Hepatitis B, Chronic
Academic Article Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.
Academic Article CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.
Academic Article Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
Academic Article Ledipasvir-Sofosbuvir for 12?Weeks in Children 3 to <6?Years Old With Chronic Hepatitis C.
Academic Article Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a.
Academic Article Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study.

Search Criteria
  • Hepatitis B Chronic

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)